Gholamalizadeh, H.; Amiri-Shahri, M.; Rasouli, F.; Ansari, A.; Baradaran Rahimi, V.; Reza Askari, V.
DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target? Brain Sci. 2024, 14, 737.
https://doi.org/10.3390/brainsci14080737
AMA Style
Gholamalizadeh H, Amiri-Shahri M, Rasouli F, Ansari A, Baradaran Rahimi V, Reza Askari V.
DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target? Brain Sciences. 2024; 14(8):737.
https://doi.org/10.3390/brainsci14080737
Chicago/Turabian Style
Gholamalizadeh, Hanieh, Maedeh Amiri-Shahri, Fatemeh Rasouli, Arina Ansari, Vafa Baradaran Rahimi, and Vahid Reza Askari.
2024. "DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target?" Brain Sciences 14, no. 8: 737.
https://doi.org/10.3390/brainsci14080737
APA Style
Gholamalizadeh, H., Amiri-Shahri, M., Rasouli, F., Ansari, A., Baradaran Rahimi, V., & Reza Askari, V.
(2024). DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target? Brain Sciences, 14(8), 737.
https://doi.org/10.3390/brainsci14080737